Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 5
1998 2
2000 1
2001 1
2002 1
2004 3
2005 3
2006 1
2007 5
2008 3
2009 3
2010 6
2011 4
2012 4
2013 8
2014 4
2015 6
2016 7
2017 7
2018 11
2019 8
2020 9
2021 11
2022 11
2023 6
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Biology of the BKPyV: An Update.
Helle F, Brochot E, Handala L, Martin E, Castelain S, Francois C, Duverlie G. Helle F, et al. Among authors: castelain s. Viruses. 2017 Nov 3;9(11):327. doi: 10.3390/v9110327. Viruses. 2017. PMID: 29099746 Free PMC article. Review.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Gaborit B, Vanhove B, Lacombe K, Guimard T, Hocqueloux L, Perrier L, Dubee V, Ferre V, Bressollette C, Josien R, Thuaut AL, Vibet MA, Jobert A, Dailly E, Ader F, Brouard S, Duvaux O, Raffi F; POLYCOR study group. Gaborit B, et al. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad525. doi: 10.1093/ofid/ofad525. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37942459 Free PMC article.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Genetic recombination of the hepatitis C virus: clinical implications.
Morel V, Fournier C, François C, Brochot E, Helle F, Duverlie G, Castelain S. Morel V, et al. Among authors: castelain s. J Viral Hepat. 2011 Feb;18(2):77-83. doi: 10.1111/j.1365-2893.2010.01367.x. Epub 2010 Sep 6. J Viral Hepat. 2011. PMID: 21235686 Review.
Simeprevir for the treatment of hepatitis C virus infection.
Izquierdo L, Helle F, François C, Castelain S, Duverlie G, Brochot E. Izquierdo L, et al. Among authors: castelain s. Pharmgenomics Pers Med. 2014 Aug 14;7:241-9. doi: 10.2147/PGPM.S52715. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25206310 Free PMC article. Review.
Which therapeutic option for hepatitis C virus genotype 1?
Brochot E, Helle F, François C, Castelain S, Capron D, Nguyen-Khac E, Duverlie G. Brochot E, et al. Among authors: castelain s. Scand J Gastroenterol. 2015 Apr;50(4):470-8. doi: 10.3109/00365521.2014.978364. Epub 2014 Nov 14. Scand J Gastroenterol. 2015. PMID: 25396710 Review.
115 results